Abnormalities in the bone mineral metabolism in HIV-infected patients
- 6 October 2005
- journal article
- clinical trial
- Published by Springer Nature in Clinical Rheumatology
- Vol. 25 (4) , 537-539
- https://doi.org/10.1007/s10067-005-0028-x
Abstract
To evaluate bone mineral metabolism in HIV infected and asymptomatic patients receiving highly active antiretroviral therapy (HAART) containing protease inhibitors (PI) and naïve patients. We studied 30 asymptomatic HIV infected male patients, 13 in the naive group and 17 in the IP group, both without differences in demographics characteristics. We excluded women and patients with any known factor associated to osteopenia. We did a nutritional questionnaire, a DEXA scan in lumbar spine and femur, a study of CD4 lymphocytes, viral load and an analysis of bone formation and resorption markers in all patients. We compared vitamin D and PTH levels with a control group of healthy male volunteers age-pareated. For the statistical analysis we used the SPSS program. Osteopenia was present in 17/30 (57%), 8/13 (61.5%) in the naïve group and 9/17 (53%) in the PI group (not significant differences). We found a vitamin D deficiency in 86% of patients, with mean serum levels that was found to be significantly lower than those from a healthy control group (p=0.04). Testosterone level was significantly related to bone mineral density in lumbar spine (p</=0.05). HIV may be an individual risk factor in bone disorders, requiring calcium and vitamin D supplementation.Keywords
This publication has 11 references indexed in Scilit:
- Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapyAIDS, 2003
- HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin DAIDS, 2003
- Relationship Between Serum Vitamin D Status and Clinical Manifestations of Primary HyperparathyroidismEndocrine Practice, 2002
- Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavirAIDS, 2001
- A Global Study of Vitamin D Status and Parathyroid Function in Postmenopausal Women with Osteoporosis: Baseline Data from the Multiple Outcomes of Raloxifene Evaluation Clinical TrialJournal of Clinical Endocrinology & Metabolism, 2001
- Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapyAIDS, 2000
- Alta prevalencia de deficiencia de vitamina D en mujeres posmenopáusicas de una consulta reumatológica en Madrid. Evaluación de dos pautas de prescripción de vitamina DMedicina Clinica, 2000
- Severe Deficiency of 1,25-Dihydroxyvitamin D3 in Human Immunodeficiency Virus Infection: Association with Immunological Hyperactivity and Only Minor Changes in Calcium HomeostasisJournal of Clinical Endocrinology & Metabolism, 1998
- Abnormal fat distribution and use of protease inhibitorsThe Lancet, 1998
- Differences in vitamin D status between countries in young adults and the elderlyThe American Journal of Medicine, 1992